Cancer therapy pioneer uses the word ‘cure’ after CAR-T breakthrough
A new longitudinal study of cancer patients treated with a revolutionary type of cell therapy...
A new longitudinal study of cancer patients treated with a revolutionary type of cell therapy...
Cancer is one of the significant causes of death worldwide. As per the World Health...
Biopharmaceutical company Prescient Therapeutics Limited (ASX: PTX) engaged in evolving personalized therapies for cancer has released its...
Prescient Therapeutics (ASX: PTX) Managing Director and Chief Executive Officer Steven Yatomi-Clarke joins Kalkine Media...
Clinical-stage oncology company Prescient Therapeutics (ASX: PTX) has announced it has ended the December quarter with a...
With around $15m in the bank, Prescient is pressing ahead to move its novel OmniCAR...
To fight the menace of cancer, there have been categorical and highly efficacious progress in...
A clinical-stage oncology company, Prescient Therapeutics (ASX:PTX) has further strengthened its Scientific Advisory Board (SAB) with the...
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has made plans to advance and accelerate its proprietary...
Biotechnology companies have emerged from the COVID pandemic in “healthy if not robust” shape and...
This investor centre was built by Reach Markets
©2025 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.